Catena Biosciences
Daniel A. Gutierrez is a skilled scientist currently working at CatenaBio since June 2022. Prior to this role, Daniel completed a PhD program in Neuroscience at the University of Massachusetts Medical School from June 2013 to May 2022, where significant research included developing a novel method for repurposing intracellular fluorescent biosensors and earning a NINDS NIH F31 Fellowship. Daniel also served as a Research Associate at the Gene Therapy Center, focusing on AAV vector production optimization. Earlier experience includes working as an Assistant Lab Manager at Impossible Foods, where responsibilities included coordinating a company relocation and assisting in facility design. Daniel began their research career as a Biomedical Researcher at San Jose State University, studying microRNA expression in cervical carcinoma, and contributed as an NSF-REU Researcher. Daniel earned a B.S. in Biological Sciences with a focus on Molecular Biology from San Jose State University in 2012.
Catena Biosciences
Catena Biosciences was founded in 2020 based on technology developed in the Francis and Doudna Labs at UC Berkeley. Their platform allows for the rapid coupling of proteins for the creation of novel therapeutics in autoimmune disorders, oncology, and vaccine development.